MILLENNIUM MANAGEMENT LLC - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 212 filers reported holding REATA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.8%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$60,326,061
+275726.7%
591,664
+146.0%
0.03%
+150.0%
Q1 2023$21,871
-37.0%
240,560
-73.7%
0.01%
-36.8%
Q4 2022$34,718
-99.8%
913,872
+46.9%
0.02%
+111.1%
Q3 2022$15,633,000
+237.4%
622,093
+308.0%
0.01%
+200.0%
Q2 2022$4,633,000
-66.9%
152,466
-64.3%
0.00%
-62.5%
Q1 2022$14,006,000
-12.8%
427,541
-29.8%
0.01%0.0%
Q4 2021$16,058,000
+557.8%
608,951
+2409.8%
0.01%
+700.0%
Q3 2021$2,441,000
-75.7%
24,263
-75.9%
0.00%
-85.7%
Q1 2021$10,043,000
-53.7%
100,723
-42.6%
0.01%
-56.2%
Q4 2020$21,688,000
-33.3%
175,443
-47.4%
0.02%
-60.0%
Q3 2020$32,520,000
-43.4%
333,807
-9.3%
0.04%
-49.4%
Q2 2020$57,443,000
+79.0%
368,177
+65.6%
0.08%
+9.7%
Q1 2020$32,088,000
-43.0%
222,306
-19.2%
0.07%
+1.4%
Q4 2019$56,255,000
+103.4%
275,183
-20.1%
0.07%
+65.1%
Q3 2019$27,664,000
-43.4%
344,575
-33.5%
0.04%
-41.9%
Q2 2019$48,879,000
+17.0%
518,061
+6.0%
0.07%
+17.5%
Q1 2019$41,788,000
+449.1%
488,925
+260.4%
0.06%
+425.0%
Q4 2018$7,610,000
-6.5%
135,658
+36.3%
0.01%
+20.0%
Q3 2018$8,139,000
+2551.1%
99,542
+1033.6%
0.01%
Q2 2018$307,000
-73.4%
8,781
-76.4%
0.00%
-100.0%
Q3 2017$1,155,000
+58.9%
37,147
+15.7%
0.00%
+100.0%
Q1 2017$727,000
-23.6%
32,108
-26.3%
0.00%
-50.0%
Q4 2016$951,00043,5540.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
CPMG Inc 2,896,901$291,457,00032.14%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 46,646$4,693,0005.31%
Ikarian Capital, LLC 471,400$47,423,0003.34%
Duquesne Family Office 695,033$69,927,0002.27%
Camber Capital Management LP 685,000$68,918,0002.12%
LBJ Family Wealth Advisors, Ltd. 30,359$3,054,0001.82%
MADDEN SECURITIES Corp 33,127$3,333,0001.80%
Biondo Investment Advisors, LLC 104,120$10,475,0001.80%
Tolleson Wealth Management, Inc. 60,750$6,112,0001.73%
Keel Point, LLC 97,074$9,767,0001.26%
View complete list of REATA PHARMACEUTICALS INC shareholders